# A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain

> **NCT04014478** · NA · UNKNOWN · sponsor: **Shanghai Golden Leaf MedTec Co. Ltd** · enrollment: 110 (estimated)

## Conditions studied

- Liver Cancer
- Pancreas Cancer
- Stomach Cancer
- Bile Duct Cancer

## Interventions

- **DEVICE:** Endovascular Denervation

## Key facts

- **NCT ID:** NCT04014478
- **Lead sponsor:** Shanghai Golden Leaf MedTec Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-15
- **Primary completion:** 2021-07-15
- **Final completion:** 2021-07-15
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014478, "A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04014478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*